Abstract
Biosimilars are the biologic medical products highly similar to an already approved reference biologic with no clinically meaningful difference in terms of safety,purity,and potency .they are developed after the original biologics patent expires and are subjected to rigorous regulatory evaluation to ensure their efficacy and safety .Biosimilars offer a cost - effective alternative to biologics ,fostering in the pharmaceutical market and increasing patient access to treatments fo br various chronic and life threatening diseases and auto immune disorders. Biosimilars are made from the same type of sources (eg:living organisms like bacteria(e.coli, bacilius subtilis) mammalian cells lines (HEK293,NSO) plant based system (tobacco ,corn ). Biosimilars is a biologic medication.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal For Multidisciplinary Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
